| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.41 | 0.01 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |